ReviewCureus2026
Artificial Intelligence and Robotics in General Surgery: Opportunities and Challenges.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence and robotics are reshaping general surgery across the full perioperative continuum. This narrative review traces the history of surgical robotics from early teleoperated systems developed by NASA and the US Department of Defense to the current da Vinci Xi and SP platforms and examines how AI is now being applied at each phase of surgical care. In the preoperative setting, machine learning models outperform traditional risk scores in predicting postoperative complications, while deep learning applied to computed tomography (CT) and magnetic resonance imaging (MRI) improves tumor detection, lymph node staging, and surgical planning. Intraoperatively, AI-driven phase recognition systems achieve 85-95% accuracy in identifying procedural steps, computer vision tools assess the Critical View of Safety during laparoscopic cholecystectomy, and semi-autonomous robotic systems are beginning to reduce surgeon tremor and automate discrete operative tasks. In the postoperative period, AI-integrated wearable biosensors and electronic health record models enable earlier detection of complications such as sepsis and deep vein thrombosis, while personalized ERAS protocols are refined through continuous data streams. Despite these advances, significant challenges remain, including dataset bias, limited external validation, black-box model opacity, and unresolved questions around data privacy, liability, and regulatory oversight. AI currently functions as a decision-support tool rather than an autonomous actor. Broader clinical adoption will require larger multi-institutional datasets, improved model interpretability, and clear regulatory frameworks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.